AlloDirect
As of 22 Oct 2026, AlloDirect has raised $900K across 1 verified round on record; latest: $900,000 pre-seed round led by M25, announced Sep 2026.
As of 22 Oct 2026, AlloDirect has raised $900K across 1 verified round on record; latest: $900,000 pre-seed round led by M25, announced Sep 2026.
A direct sourcing platform connecting AATB-accredited tissue banks with surgery centers, hospitals and health systems
allo.directValparaiso, IndianaHealthtechFounded 2025
5 sources · checked 1 time, last 2h ago
The sources identify only generic angel participation; no individual angels or additional investing firms are named.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Pre-seed | $900K | ~ 2026-09-25 | M25 | No recent discussion |
5 sources · checked 1 time, last 2h ago [ VERIFIED ] read against 4 of 5 sources The sources identify only generic angel participation; no individual angels or additional investing firms are named. | ||||
AlloDirect is a direct-sourcing platform that lets surgery centers, hospitals, and health systems search and order human-tissue grafts from AATB-accredited tissue banks in one workflow.
AlloDirect targets the slow, opaque intermediary layer in allograft procurement, where facilities can wait days for availability information, pay markups, and waste tissue that expires on shelves. Its bet is that a single catalog and ordering layer—already processing orders across five states and listing more than 24,000 allografts from six accredited banks—can reduce cost and waste as more musculoskeletal surgery shifts to outpatient settings, with the M25-led pre-seed funding continued platform development and first hires.
Checked against 8 sources on Sep 26